icatibant acetate
PolandDrugs containing this active substance
-
The medicine is intended for the treatment of symptoms of hereditary angioedema (HAE) in adults and in adolescents and children aged 2 years and older.
Form: solution for injection in ampoule-syringe
Active substance Dosage icatibant acetate 31.4 mg ATC: B06AC02
Manufacturer: Universal Farma, S.L.
-
The medicine is intended for the treatment of symptoms of hereditary angioedema (HAE) in adults as well as in adolescents and children aged 2 years and older.
Form: solution for injection in ampoule-syringe
Active substance Dosage icatibant acetate 31.4 mg ATC: B06AC02
Manufacturer: Universal Farma, S.L.
-
The medicinal product is intended for the treatment of symptoms of hereditary angioedema (HAE) in adults and in adolescents and children aged 2 years and older.
Form: solution for injection in ampoule-syringe
Active substance Dosage icatibant acetate 30 31.38-35.52 mg/3.0 ml ATC: B06AC02
Manufacturer: Eurofins Proxy Laboratories B.V. Pharmadox Healthcare Ltd.